Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma （GTN） Patients With Score of 5-6

NCT03885388 PHASE2, PHASE3 UNKNOWN

In this study, a prospective, multicenter randomized controlled study was conducted to compare the clinical efficacy and toxicity response of combination MTX+ACTD multi-course regimen in low-risk GTN patients with score 5-6 with standard MTX single-drug multi-course regimen.

Details

Lead sponsor	Women's Hospital School Of Medicine Zhejiang University
Phase	PHASE2, PHASE3
Status	UNKNOWN
Enrolment	300
Start date	Fri Mar 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sun Dec 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Gestational Trophoblastic Tumor
• Effects of Chemotherapy
• Drug Toxicity

Interventions

• MTX
• MTX+ACTD

Countries

China